Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Farhat Nasim

Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Farhat Nasim

Articles By : Farhat Nasim

Drug samples including cough-cold syrup fails quality test, declared Not Of Standard Quality

Farhat Nasim17 Jun 2020 6:09 PM IST

New Delhi: The apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) flagged 59 drug samples that failed to qualify a random...

Unfortunate: Mumbai doctor succumbs to COVID-19

Farhat Nasim17 Jun 2020 9:15 AM IST

Mumbai: In an unfortunate incident, a senior female doctor attached with civic-run Chatrapati Shivaji Maharaj Hospital in Kalwa succumbed to...

Defective COVID Test Kits: Licence for Chinese kits issued only after validation, DCGI tells court

Farhat Nasim16 Jun 2020 4:52 PM IST

The court was further informed via a counter affidavit by the Indian Council of Medical Research (ICMR) that clarified that the kits of Guangzhou...

18 Medical Device Firms Got Rs 133.95 Cr in Incentives Till FY2024-25: Govt Tells RS

DoP presents draft guidelines for Rs 6500-crore pharma incentive scheme; Details

Farhat Nasim15 Jun 2020 6:04 PM IST

New Delhi: Through a recent notification, the Department of Pharmaceuticals(DoP) has rolled out draft guidelines for the Rs 6,940 crore...

Delhi HC restrains firm from using trademark similar to Sun Pharma BP drug Labebet

Farhat Nasim14 Jun 2020 12:45 PM IST

New Delhi: In a major relief to drug giant, Sun Pharmaceuticals Laboratories Limited, the Delhi High Court has recently restrained BDR Pharmaceuticals...

Combating COVID-19: India to soon begin domestic production of Remdesivir drug

Farhat Nasim14 Jun 2020 10:15 AM IST

"Pharma companies have been directed to conduct Active-Post Marketing Surveillance of each case and prepare a report on the benefit or recovery of a...

Sun Pharma presents Clinical Insights of ODOMZO, LEVULAN KERASTICK for Treating People With Risk of Skin Cancer

Farhat Nasim14 Jun 2020 10:15 AM IST

Mumbai: Sun Pharmaceutical Industries Ltd. recently announced that one of its wholly-owned subsidiaries presented data analyses for two of its...

Sun Pharma announces insights into clinical use of ILUMYA in moderate-to-severe plaque psoriasis

Farhat Nasim13 Jun 2020 11:54 AM IST

Furthermore, the safety profile of ILUMYA was reconfirmed in a five-year analysis that demonstrated low and similar exposure-adjusted incidence rates...

NPPA Fixes Retail Price Of 3 Formulations; Details

Farhat Nasim13 Jun 2020 10:30 AM IST

These include some popular combination drugs namely Vildagliptin + Metformin Tablet manufactured by Morepen Laboratories Ltd; Escitalopram +...

Ascent backed-Naari buys 10 ANDAs from Intas Pharma

Farhat Nasim12 Jun 2020 3:07 PM IST

The portfolio acquired comprises eight U.S. FDA approved ANDAs and two products pending approval. It includes generic products in female hormones...

SRL lab asked to pay Rs 99 lakh compensation for allegedly wrongly diagnosing lawyer with COVID

Farhat Nasim12 Jun 2020 2:28 PM IST

Mumbai: Blaming the private laboratory for providing an incorrect COVID positive report, a city-based lawyer has sent a legal notice to SRL...

Gandhi Hospital: Two Attendants of COVID victim held for assaulting junior doctor with iron stand

Farhat Nasim11 Jun 2020 6:04 PM IST

The incident triggered protests by doctors who demanded additional security to prevent such incidents and deployment of special protection force at...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok